跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Calzeesaph - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Calzeesaph
Approved
STANDARD
Calzeesaph
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4d5b7463243d59a0
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
4d5b7463243d59a0
Drug Approval Philippines Name
Calzeesaph
Product Name
Calzeesaph
Registration Number
DRP-9498
Brand Name
Calzeesaph
Generic Name
Calcium Ascorbate + Zinc
Dosage Form
Capsule
Dosage Strength
500 mg (equivalent to 605.19 mg Calcium Ascorbate)/ 20 mg (equivalent to 55 mg Zinc Sulfate Monohydrate)
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Issuance Date
25 January 2021
Expiry Date
25 January 2026
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4d5b7463243d59a0
Type
Standard
Back to Philippines FDA Approvals